№ lp_1_2_53236
File format: docx Character count: 5987 File size: 30 KB
The document outlines a submission to the Pharmaceutical Benefits Advisory Committee (PBAC) regarding the reformulation of Kindergen®, a whey protein formula supplement, to meet new European compositional standards for infant nutrition.
Year: 2026
Region / City: Australia
Topic: Nutritional Formulation, Food for Special Medical Purposes
Document Type: Submission to PBAC
Organization / Institution: PBAC, Nutricia Australia Pty Ltd
Author: Nutricia Australia Pty Ltd
Target Audience: Healthcare professionals, regulatory bodies, pediatricians
Validity Period: Ongoing
Approval Date: 1 August 2002
Date of Change: 2011, 2026
Requested Change: Formulation modification to comply with EU regulations
Status: Approved for continued listing
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Driving pea and whey protein hydrolysis towards the development of hybrid beverages with improved foamability
Year: 2024
Region / city: Udine, Italy; Rome, Italy
Topic: Hybrid food development, Protein hydrolysis, Beverage formulation
Document type: Research Article
Organization / institution: University of Udine, San Raffaele University
Authors: G Di Filippo, N Innocente, S Melchior, S Calligaris
Target audience: Researchers, Food scientists, Industry professionals
Period of validity: Not specified
Approval date: Not specified
Date of changes: Not specified
MILK POWDER - LACTOSE INTOLERANCE FORMULA Oral liquid: powder for, 900 g can, S-26® Original LI, Aspen Pharmacare Australia Pty Ltd
Note: Year
Topic: Lactose intolerance formula, medical foods
Document Type: Submission for PBS listing
Agency / Organization: PBAC (Pharmaceutical Benefits Advisory Committee)
Author: Aspen Pharmacare Australia Pty Ltd
Target Audience: Healthcare professionals (prescribers, including medical practitioners, nurse practitioners, optometrists, midwives)
Effective Period: Ongoing
Topics: Kindergen WHEY LACTOSE